Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region.
[Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].
Astrocytic A20 ameliorates experimental autoimmune encephalomyelitis by inhibiting NF-κB- and STAT1-dependent chemokine production in astrocytes.
Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population.
Multiple sclerosis or neurological manifestations of Celiac disease.
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
The use of laboratory gait analysis for understanding gait deterioration in people with multiple sclerosis.
Deletion of jun proteins in adult oligodendrocytes does not perturb cell survival, or myelin maintenance in vivo.
Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology.
The crystal structure of an integral membrane fatty acid α-hydroxylase.
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activity.
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.
Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells.
Sonographic evaluation of peripheral nerves in subtypes of Guillain-Barré syndrome.
Efficacy of Schwann Cell (SC) transplantation for spinal cord repair is improved with combinatorial strategies.
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Postural control, falls and fear of falling in people with multiple sclerosis without mobility aids.
Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.
Pages
« first
‹ previous
…
711
712
713
714
715
716
717
718
719
…
next ›
last »